According to Intellia Therapeutics's latest financial reports the company's current revenue (TTM) is $36.27 M. In 2022 the company made a revenue of $52.12 M an increase over the years 2021 revenue that were of $33.05 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $36.27 M | -30.4% |
2022 | $52.12 M | 57.69% |
2021 | $33.05 M | -43.01% |
2020 | $57.99 M | 34.55% |
2019 | $43.1 M | 41.63% |
2018 | $30.43 M | 16.53% |
2017 | $26.11 M | 58.49% |
2016 | $16.47 M | 172.65% |
2015 | $6.04 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |